Table 5 The DBE findings of patients with PSIL
DLBCL | indolent B-cell lymphoma | p value | DLBCL | T-cell lymphoma | p value | |
|---|---|---|---|---|---|---|
Lesion sites | ||||||
Duodenum (n, %) | 0 (0.0) | 2 (18.2) | 0.476 | 0 (0.0) | 3 (33.3) | 0.087 |
Jejunum (n, %) | 4 (40.0) | 7 (63.6) | 0.395 | 4 (40.0) | 6 (66.7) | 0.370 |
Ileum (n, %) | 7 (70.0) | 5 (45.5) | 0.387 | 7 (70.0) | 4 (44.4) | 0.370 |
Ileocecal valve involved (n, %) | 0 (0.0) | 0 (0.0) | — | 0 (0.0) | 1 (11.1) | 0.474 |
Ulcers (n, %) | 10 (90.9) | 9(81.8) | 1.000 | 10 (90.9) | 8 (88.9) | 1.000 |
Longitudinal ulcers (n, %) | 0 (0.0) | 0 (0.0) | — | 0 (0.0) | 1 (11.1) | 0.474 |
Round ulcers (n, %) | 3 (30.0) | 5 (45.5) | 0.659 | 3 (30.0) | 3 (33.3) | 1.000 |
Irregular ulcers (n, %) | 7 (70.0) | 2 (18.2) | 0.030 | 7 (70.0) | 4 (44.4) | 1.000 |
Deep ulcers# (n, %) | 8 (80.0) | 2 (18.2) | 0.009 | 8 (80.0) | 6 (66.7) | 0.628 |
Concomitant colonic ulcers (n, %) | 1 (10.0) | 0 (0.0) | 0.476 | 1 (10.0) | 0 (0.0) | 1.000 |
Moss covered (n, %) | 7 (70.0) | 3 (23.3) | 0.086 | 7 (70.0) | 7 (77.8) | 1.000 |
Stenosis (n, %) | 3 (30.0) | 4 (36.4) | 1.000 | 3 (30.0) | 3 (33.3) | 1.000 |
Villous atrophy (n, %) | 0 (0.0) | 1 (9.1) | 1.000 | 0 (0.0) | 1 (11.1) | 0.474 |